Background Although health problems may persist beyond 4 weeks after SARS-CoV-2 infection, evidence on long-term ophthalmic ...

Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The virologist had recently started an independent group at the University of Tokyo ...

A multi-institutional study led by researchers at the University of Alabama at Birmingham and the University of North Carolina at Chapel Hill has revealed a previously underappreciated mechanism by ...

This week, I'm turning my column over to Jonathan Karn, PhD, Professor and Chair, Department of Molecular Biology and Microbiology, and Director, Case Center for AIDS Research. Many people would like ...

The global pandemic may be over, but SARS-CoV-2 continues to infect people around the world. Indeed, the United States has recorded roughly 750 deaths from COVID-19 over the past month. Now, an siRNA ...

A new study led by researchers at the University of Malaga proposes a new antiviral strategy against SARS-CoV-2—the virus ...

Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...

A landmark study shows that bat viruses closely related to SARS-CoV-1 and SARS-CoV-2 emerged far from outbreak sites, pointing to the wildlife trade, not natural bat movement, as the most plausible ...

This new research, published in the Genes & Diseases journal by a team from Hunan University, Texas A&M University Colleges ...

A new variant of the SARS-CoV-2 virus, dubbed Cicada, is less susceptible to vaccination and appears to discriminate based on ...